Phenomenex Inc., a Danaher Company and a global leader in separation science technologies, has announced the launch of the new Luna Omega HILIC LC Columns. These columns are designed to deliver robust and improved separations of highly polar and hydrophilic compounds, addressing the growing analytical demand for sensitive and consistent HILIC separations in biopharmaceutical, metabolomics, clinical, environmental, and food testing applications.
Enhanced Performance for Polar Compounds
The new column expands the trusted Luna Omega portfolio into hydrophilic interaction liquid chromatography (HILIC). It combines Phenomenex's established silica expertise with modern surface chemistry engineered for enhanced method reliability, resolution, and compatibility with UHPLC workflows. This innovation aims to simplify HILIC method development while maintaining the selectivity and reproducibility expected from the Luna Omega family.
Expert Insights on the Launch
“As method development challenges continue to evolve, scientists are asking for more reliable HILIC performance without the complexity traditionally associated with these methods,” said Dr. Lauryn Bailey, Vice President of Global Sales & Marketing at Phenomenex. “Luna Omega HILIC was developed to simplify HILIC method development while maintaining the selectivity and reproducibility our customers expect from the Luna Omega family.”
Growing Importance of HILIC
HILIC continues to grow in importance for compounds that cannot be adequately retained in reversed-phase chromatography, including small polar metabolites, polar APIs, nucleotides, amino acids, and other hydrophilic analytes. Luna Omega HILIC is engineered with these workflows in mind, offering predictable performance and reduced variability—key considerations for regulated environments and high-throughput laboratories.
Upcoming Symposium
Phenomenex will highlight the new Luna Omega HILIC LC Columns and discuss HILIC best practices at the 55th International Symposium on High Performance Liquid Phase Separations and Related Techniques (HPLC 2026), scheduled from June 6 to 11.
About Phenomenex
Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve separation and purification challenges for researchers in academic, pharmaceutical, biotech, environmental, clinical research, government, and industrial laboratories. From drug discovery to food safety, Phenomenex chromatography solutions accelerate science and improve human health.
About Danaher
Danaher is a leading global life sciences and diagnostics innovator, dedicated to accelerating the power of science and technology to improve human health. Through a connected ecosystem of industry-leading businesses, Danaher works with customers to solve complex scientific and clinical challenges, helping move innovations from discovery to delivery faster.
For more information, visit Phenomenex’s website or follow the company’s blog at Science Unfiltered.
